198 related articles for article (PubMed ID: 38256429)
1. Transient Elastography Is the Best-Performing Non-Invasive Test of Liver Fibrosis in Obese Asian Patients with Non-Alcoholic Fatty Liver Disease: A Pilot, Cross-Sectional Study.
Kalaiyarasi K; Sanchalika A; Hsien Min L; Wei Ming Y; Vishalkumar S; Kuo Chao Y; Jee Keem L; Sameer J; Terence HCW; Yen Ping T
Medicina (Kaunas); 2024 Jan; 60(1):. PubMed ID: 38256429
[No Abstract] [Full Text] [Related]
2. Comparison of 2D Shear Wave Elastography, Transient Elastography, and MR Elastography for the Diagnosis of Fibrosis in Patients With Nonalcoholic Fatty Liver Disease.
Furlan A; Tublin ME; Yu L; Chopra KB; Lippello A; Behari J
AJR Am J Roentgenol; 2020 Jan; 214(1):W20-W26. PubMed ID: 31714842
[No Abstract] [Full Text] [Related]
3. Poor Performance of Non-invasive Tests for Advanced Fibrosis in Nonalcoholic Fatty Liver Disease: A Multicentric Asian Study.
Arora U; Goyal RM; Teh KKJ; Pei Y; Goh GBB; Lin S; Kumar R; Biswas S; Vaishnav M; Swaroop S; Pathak P; Sheikh S; Bharadiya V; Elhence A; Gamanagatti S; Yadav R; Das P; Aggarwal S; Choudhary N; Anirvan P; Singh SP; De A; Duseja A; Shalimar
Dig Dis Sci; 2023 Dec; 68(12):4485-4498. PubMed ID: 37733130
[TBL] [Abstract][Full Text] [Related]
4. Comparative diagnostic accuracy of magnetic resonance elastography vs. eight clinical prediction rules for non-invasive diagnosis of advanced fibrosis in biopsy-proven non-alcoholic fatty liver disease: a prospective study.
Cui J; Ang B; Haufe W; Hernandez C; Verna EC; Sirlin CB; Loomba R
Aliment Pharmacol Ther; 2015 Jun; 41(12):1271-80. PubMed ID: 25873207
[TBL] [Abstract][Full Text] [Related]
5. Comparison of point shear wave elastography and transient elastography in the evaluation of patients with NAFLD.
Argalia G; Ventura C; Tosi N; Campioni D; Tagliati C; Tufillaro M; Cucco M; Svegliati Baroni G; Giovagnoni A
Radiol Med; 2022 May; 127(5):571-576. PubMed ID: 35290569
[TBL] [Abstract][Full Text] [Related]
6. Comparison of laboratory tests, ultrasound, or magnetic resonance elastography to detect fibrosis in patients with nonalcoholic fatty liver disease: A meta-analysis.
Xiao G; Zhu S; Xiao X; Yan L; Yang J; Wu G
Hepatology; 2017 Nov; 66(5):1486-1501. PubMed ID: 28586172
[TBL] [Abstract][Full Text] [Related]
7. Magnetic Resonance vs Transient Elastography Analysis of Patients With Nonalcoholic Fatty Liver Disease: A Systematic Review and Pooled Analysis of Individual Participants.
Hsu C; Caussy C; Imajo K; Chen J; Singh S; Kaulback K; Le MD; Hooker J; Tu X; Bettencourt R; Yin M; Sirlin CB; Ehman RL; Nakajima A; Loomba R
Clin Gastroenterol Hepatol; 2019 Mar; 17(4):630-637.e8. PubMed ID: 29908362
[TBL] [Abstract][Full Text] [Related]
8. Liver stiffness accuracy by magnetic resonance elastography in histologically proven non-alcoholic fatty liver disease patients: a Spanish cohort.
Lara Romero C; Liang JX; Fernández Lizaranzazu I; Ampuero Herrojo J; Castell J; Del Prado Alba C; Domínguez Pascual I; Romero Gómez M
Rev Esp Enferm Dig; 2023 Apr; 115(4):162-167. PubMed ID: 35791792
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic accuracy of elastography and magnetic resonance imaging in patients with NAFLD: A systematic review and meta-analysis.
Selvaraj EA; Mózes FE; Jayaswal ANA; Zafarmand MH; Vali Y; Lee JA; Levick CK; Young LAJ; Palaniyappan N; Liu CH; Aithal GP; Romero-Gómez M; Brosnan MJ; Tuthill TA; Anstee QM; Neubauer S; Harrison SA; Bossuyt PM; Pavlides M;
J Hepatol; 2021 Oct; 75(4):770-785. PubMed ID: 33991635
[TBL] [Abstract][Full Text] [Related]
10. Transient hepatic elastography has the best performance to evaluate liver fibrosis in non-alcoholic fatty liver disease (NAFLD).
Tovo CV; Villela-Nogueira CA; Leite NC; Panke CL; Port GZ; Fernandes S; Buss C; Coral GP; Cardoso AC; Cravo CM; Calçado FL; Rezende GFM; Ferreira FC; Araujo-Neto JM; Perez RM; Moraes-Coelho HS; de Mattos AA
Ann Hepatol; 2019; 18(3):445-449. PubMed ID: 31031166
[TBL] [Abstract][Full Text] [Related]
11. Transient elastography for diagnosis of stages of hepatic fibrosis and cirrhosis in people with alcoholic liver disease.
Pavlov CS; Casazza G; Nikolova D; Tsochatzis E; Burroughs AK; Ivashkin VT; Gluud C
Cochrane Database Syst Rev; 2015 Jan; 1(1):CD010542. PubMed ID: 25612182
[TBL] [Abstract][Full Text] [Related]
12. New sequential combinations of non-invasive fibrosis tests provide an accurate diagnosis of advanced fibrosis in NAFLD.
Boursier J; Guillaume M; Leroy V; Irlès M; Roux M; Lannes A; Foucher J; Zuberbuhler F; Delabaudière C; Barthelon J; Michalak S; Hiriart JB; Peron JM; Gerster T; Le Bail B; Riou J; Hunault G; Merrouche W; Oberti F; Pelade L; Fouchard I; Bureau C; Calès P; de Ledinghen V
J Hepatol; 2019 Aug; 71(2):389-396. PubMed ID: 31102719
[TBL] [Abstract][Full Text] [Related]
13. A comparison of FibroMeter™ NAFLD Score, NAFLD fibrosis score, and transient elastography as noninvasive diagnostic tools for hepatic fibrosis in patients with biopsy-proven non-alcoholic fatty liver disease.
Aykut UE; Akyuz U; Yesil A; Eren F; Gerin F; Ergelen R; Celikel CA; Yilmaz Y
Scand J Gastroenterol; 2014 Nov; 49(11):1343-8. PubMed ID: 25259621
[TBL] [Abstract][Full Text] [Related]
14. Systematic review and meta-analysis: non-invasive detection of non-alcoholic fatty liver disease related fibrosis in the obese.
Ooi GJ; Mgaieth S; Eslick GD; Burton PR; Kemp WW; Roberts SK; Brown WA
Obes Rev; 2018 Feb; 19(2):281-294. PubMed ID: 29119725
[TBL] [Abstract][Full Text] [Related]
15. Association Between Obesity and Discordance in Fibrosis Stage Determination by Magnetic Resonance vs Transient Elastography in Patients With Nonalcoholic Liver Disease.
Caussy C; Chen J; Alquiraish MH; Cepin S; Nguyen P; Hernandez C; Yin M; Bettencourt R; Cachay ER; Jayakumar S; Fortney L; Hooker J; Sy E; Valasek MA; Rizo E; Richards L; Brenner DA; Sirlin CB; Ehman RL; Loomba R
Clin Gastroenterol Hepatol; 2018 Dec; 16(12):1974-1982.e7. PubMed ID: 29104128
[TBL] [Abstract][Full Text] [Related]
16. An individual patient data meta-analysis to determine cut-offs for and confounders of NAFLD-fibrosis staging with magnetic resonance elastography.
Liang JX; Ampuero J; Niu H; Imajo K; Noureddin M; Behari J; Lee DH; Ehman RL; Rorsman F; Vessby J; Lacalle JR; Mózes FE; Pavlides M; Anstee QM; Harrison SA; Castell J; Loomba R; Romero-Gómez M;
J Hepatol; 2023 Sep; 79(3):592-604. PubMed ID: 37121437
[TBL] [Abstract][Full Text] [Related]
17. Novel 3D Magnetic Resonance Elastography for the Noninvasive Diagnosis of Advanced Fibrosis in NAFLD: A Prospective Study.
Loomba R; Cui J; Wolfson T; Haufe W; Hooker J; Szeverenyi N; Ang B; Bhatt A; Wang K; Aryafar H; Behling C; Valasek MA; Lin GY; Gamst A; Brenner DA; Yin M; Glaser KJ; Ehman RL; Sirlin CB
Am J Gastroenterol; 2016 Jul; 111(7):986-94. PubMed ID: 27002798
[TBL] [Abstract][Full Text] [Related]
18. MR elastography is effective for the non-invasive evaluation of fibrosis and necroinflammatory activity in patients with nonalcoholic fatty liver disease.
Costa-Silva L; Ferolla SM; Lima AS; Vidigal PVT; Ferrari TCA
Eur J Radiol; 2018 Jan; 98():82-89. PubMed ID: 29279175
[TBL] [Abstract][Full Text] [Related]
19. Systematic screening for advanced liver fibrosis in patients with coronary artery disease: The CORONASH study.
Thévenot T; Vendeville S; Weil D; Akkouche L; Calame P; Canivet CM; Vanlemmens C; Richou C; Cervoni JP; Seronde MF; Di Martino V; Boursier J
PLoS One; 2022; 17(5):e0266965. PubMed ID: 35617294
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic accuracy and clinical impact of MRI-based technologies for patients with non-alcoholic fatty liver disease: systematic review and economic evaluation.
Bresnahan R; Duarte R; Mahon J; Beale S; Chaplin M; Bhattacharyya D; Houten R; Edwards K; Nevitt S; Maden M; Boland A
Health Technol Assess; 2023 Jul; 27(10):1-115. PubMed ID: 37839810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
